Sort
20,791 grants matching “optogenetics”
Macrophage Plasticity in Inflammatory Lung Injury
$2,281,477Asrar B. Malik · University Of Illinois At Chicago · P01 · FY2021 · HL
Molecular Mechanisms of Synapse Development and Plasticity
$2,275,608Zheng Li · National Institute Of Mental Health · ZIA · FY2025 · MH
Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models
$2,269,734Inma Cobos · Stanford University · R01 · FY2025 · AG
Functional dissection of cerebellar output circuits that orchestrate limb motor control
$2,264,420Eiman Abdel-Azim · Salk Institute For Biological Studies · RF1 · FY2022 · NS
Automated cell-type-specific electrophysiology for understanding circuit dysregulation in Alzheimer's Disease
$2,263,275Matthew J.m. Rowan · Emory University · RF1 · FY2022 · AG
Role of the lateral habenula in impulsive behavior
$2,261,506Carl Lupica · National Institute On Drug Abuse · ZIA · FY2024 · DA
Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease
$2,260,431Roger L Albin · University Of Michigan At Ann Arbor · P50 · FY2024 · NS
Construction of an integrated immune - vascular brain - chip as a platform for the study, drug screening, and treatments of Alzheimer's disease
$2,259,000Li-Huei Tsai · Massachusetts Institute Of Technology · UG3 · FY2019 · NS
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.
$2,252,723Gordon J Fishell · Broad Institute, Inc. · UH3 · FY2024 · MH
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.
$2,248,706Gordon J Fishell · Broad Institute, Inc. · UG3 · FY2019 · MH
Characterization of neuronal ensembles activated during drug-induced behavior
$2,247,613Bruce Hope · National Institute On Drug Abuse · ZIA · FY2020 · DA
Stress-induced immune reprogramming in cardiovascular disease
$2,247,317Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · HL
Illuminating the Druggable GPCR-ome
$2,245,696Bryan L Roth · Univ Of North Carolina Chapel Hill · U24 · FY2018 · DK
Illuminating the Druggable GPCR-ome
$2,243,887Bryan L Roth · Univ Of North Carolina Chapel Hill · U24 · FY2019 · DK
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,243,133Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2016 · DA
Illuminating the Druggable GPCR-ome
$2,242,958Bryan L Roth · Univ Of North Carolina Chapel Hill · U24 · FY2020 · DK
Unit on Neurons, Circuits and Behavior
$2,242,264Arash Afraz · National Institute Of Mental Health · ZIA · FY2020 · MH
Illuminating the Druggable GPCR-ome
$2,241,036Bryan L Roth · Univ Of North Carolina Chapel Hill · U24 · FY2021 · DK
Development and validation of AAV vectors to manipulate specific neuronal subtypes and circuits involved in epilepsy and psychiatric disorders across mammalian species.
$2,240,361Gordon J Fishell · Broad Institute, Inc. · UG3 · FY2020 · MH
A molecular connectomics platform for multi-scale analysis of activity-dependent synapse development and plasticity
$2,239,818Colenso McNaughton Speer · Univ Of Maryland, College Park · DP2 · FY2020 · MH
Illuminating the Druggable GPCR-ome
$2,239,055Bryan L Roth · Univ Of North Carolina Chapel Hill · U24 · FY2022 · DK
Creating Magnetically Inducible Synthetic Gene Networks for Cell and Tissue Therapies
$2,238,589Warren Christopher Ruder · University Of Pittsburgh At Pittsburgh · DP2 · FY2018 · GM
Enhancer AAV-based genetic access and manipulation of specific brain cell types implicated in aging and Alzheimer's Disease
$2,220,145Xiangmin Xu · University Of California-Irvine · R61 · FY2025 · AG
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse
$2,219,436David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Characterization of neuronal ensembles activated during drug-induced behavior
$2,215,650Bruce Hope · National Institute On Drug Abuse · ZIA · FY2016 · DA